AIHealthcare

Insitro is a privately held AI-driven therapeutics and drug discovery company that combines large-scale, high-throughput biology with advanced machine learning to decode human disease biology and design new medicines, focusing on neuroscience, metabolic diseases, ALS, liver disease and cancer. The company positions itself as a "physical AI" drug company built on causal biology, built around its Virtual Human™ causal AI engine and TherML™ (Therapeutic Machine Learning) platform to identify causal genetic drivers and design optimal small molecules, antibodies, oligonucleotides and other biologics.